Introduction

▼
Recent studies have extended the activity of vitamin D [25(OH)D] well beyond that in calcium homeostasis and bone metabolism [ 1 ] . Clinical and experimental evidence supports a role of 25(OH)D in the pathogenesis of type 2 diabetes, with eff ects on either insulin sensitivity or β-cell function, or both [ 2 , 3 ] . Patients at risk for type 2 diabetes may have lower serum levels of 25(OH) D [ 3 ] . Positive correlation between levels of 25(OH)D and insulin sensitivity, and a negative eff ect of hypovitaminosis D on β-cell function have also been observed in persons without glucose intolerance [ 4 , 5 ] . Subjects born small-for-gestational age (SGA) because of intrauterine growth restriction constitute a population at risk of early development of chronic diseases, including type 2 diabetes [ 6 ] . A series of children born SGA had increased indices of insulin resistance early in life, correlated with both in utero growth restriction and accelerated postnatal growth [ 7 -9 ] . 25(OH)D levels in ▼ This study was designed to examine differences in serum 25(OH)D levels between small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA) prepubertal children in correlation with birth weight and indices of insulin resistance and β-cell function. Sixtyfi ve nonobese children were examined at age 5-7.5 years; 27 born SGA and 38 matched AGA. Body weight, height, BMI, and waist circumference were recorded and fasting serum levels of glucose, insulin, 25(OH)D, and parathyroid hormone (PTH) were measured. The homeostasis model assessment for insulin resistance (HOMA-IR) and the β-cell function index (HOMA-β %) were estimated. The mean level of 25(OH)D was higher in the SGA group (26.2 ± 10 vs. 17.2 ± 7 ng/ ml, p < 0.01) but that of PTH was no diff erent. The insulin resistance and β-cell function indices were higher in the SGA group: HOMA-IR 1.34 ± 0.67 vs. 0.99 ± 0.53, and HOMA-β % 135 ± 56 vs. 97 ± 60 in the SGA and AGA groups, respectively. In the SGA group, 25(OH)D was correlated with HOMA-β % but not with HOMA-IR or insulin. In multiple regression, in the total cohort 25(OH)D and HOMA-IR were independently negatively correlated with birth weight (β = − 0.31, β = − 0.36, p < 0.05) respectively. In conclusion, at prepuberty severely in utero growth restricted children have increased birth weight dependent levels of 25(OH)D, which might exert a regulatory role on β-cell function.
dren, the parents of 12 did not wish their children to participate and for 5 the contact details were not found. The clinical and socio-economic characteristics of the nonparticipating children did not diff er from those of the study group. The control group comprised 38 children (19 males) born in the hospital during the same period, appropriate for gestational age (AGA), defi ned as having birth weight between the 20 th and 80 th percentiles for gestational age on local growth charts specifi c for age and gender. They were matched with the SGA children for age, gender, height, weight, body mass index (BMI), and pubertal status (stage 1 according to the Tanner criteria for puberty development). A total of 170 AGA children were initially contacted to indentify the 38 matched controls. All the study children were healthy, were not receiving drugs for any cause, and had no history of liver or renal disease or malabsorption. Exclusion criteria for both groups were: congenital malformations or genetic disorders, known metabolic disorder or chronic disease, obesity (BMI ≥ 95) at the time of the study, and a positive family history of diabetes or gestational diabetes. The study protocol was approved by the Research Ethics Committee of Ioannina University Hospital. The parents of the eligible children were contacted, their written informed consent was secured and the children were evaluated at between 5 and 7.5 years of age. The following anthropometric data were recorded: birth weight, crown to heel length, and head circumference, obtained from the birth records, and body weight, body height, BMI and waist circumference at the time of the study, measured by standard methods. z-Scores for birth weight, BMI and waist circumference were derived from appropriate reference population standards. A morning venous blood sample for biochemical determinations was collected from each child after a rigorous 12 h fast, during the winter months (December-February); recruitment was balanced between SGA and AGA children across the months. Fasting serum levels of glucose, insulin , 25(OH)D, and parathyroid hormone (PTH) were measured. Insulin was determined using an immunoenzymatic method (analyzer AXSYM, Abbott) and glucose by the glucose oxidase method. The homeostasis model assessment for insulin resistance (HOMA-IR) index and β-cell function (HOMA-β %) was used to detect the degree of insulin resistance and β-cell function, respectively [ 10 ] . HOMA-IR was assessed by the formula: [(insulin (mU/l) × glucose (mmol/I)]/22.5, and HOMA-β % by [20 × 
25(OH)D was determined by an enzyme-immunoassay (EIA) method using the kit of IDS Systems Ltd, UK. The sensitivity of the method was 5.0 nmol/l, and the intra-and interassay CVs were 5.3 % and 4.6 %, respectively. The biologically intact molecule of PTH (iPTH) was measured by a 2-site enzyme linked immunosorbent assay (ELISA) using the kit of BIOMERICA Inc.
(USA). The sensitivity of the method was 0.09 pmol/l, and the intra-and interassay CVs were 3.2 % and 7.7 %, respectively. The sample volume required for each assay was 25 μl. A detailed questionnaire was completed by the parents of each child at the time of the study, concerning outdoor activities and food consumption, with emphasis on oral vitamin D preparations and foods containing or enriched with vitamin D (i.e., oily fi sh, eggs, and fortifi ed breakfast cereals). Dietary vitamin D intake was estimated, based on the USDA food composition data ( http:// www.ars.usda.gov/nutrientdata ), and on the labels in the case of the fortifi ed breakfast cereals.
Statistical analysis
Students' t -test was used after examination of parameters for normal distribution. Simple and multiple regression analyses were conducted to defi ne relationships among the examined parameters, namely 25(OH)D level, birth weight z-scores, insulin resistance and β-cell function indices, BMI, waist circumference z-scores and age. A sample size of 65 children could defi ne a 25 % diff erence among parameters with a power of 80 % at the p < 0.05 level [ 11 ] . Statistical analyses were performed using the Stat View software package of SAS Institute Inc. (Cary, USA).
Results
▼
According to the questionnaire data, the AGA and SGA children showed no diff erences in their diet (caloric content, food type, etc.) or time spent on outdoor activity. The mean dietary vitamin D intake estimated on a weekly basis was no diff erent between the 2 groups: 990 ± 250 (SGA) and 950 ± 235 (AGA) IU/week.
As shown in • ▶ Table 1 , the mean serum level of 25(OH)D was higher in the SGA group. In 2 SGA and 20 AGA children, the level of 25(OH)D was below a cutoff value of 15 ng/ml, while in 3 of the AGA children it was below 10 ng/ml. Only 6 SGA and 2 AGA children had 25(OH)D levels above 30 ng/ml, which has recently been proposed as the cutoff of adequacy. The insulin resistance indices for fasting insulin and HOMA-IR were higher in the SGA group, while HOMA-β %, which represents β-cell function, was favorable in this group. PTH level did not diff er between the 2 groups. By comparing children with 25(OH)D levels below and above 15 ng/ml no diff erences in insulin resistance and β-cell function indices were found (data not shown).
In simple regression analysis in the SGA group, the 25-OH D level was positively correlated with HOMA-β % (R = 0.38, p < 0.05,
• ▶ Fig. 1 ), but not with HOMA-IR or fasting insulin (R = 0.16, 0.14, respectively, p = ns). In the AGA group 25-OH D was not correlated with either HOMA-β % or HOMA-IR or insulin or (R = 0.17, − 0.08, − 0.07, respectively). PTH showed no correlation with vthe metabolic indices in any group or the total cohort. [ 4 , 5 , 12 -14 ] , although these fi ndings were not confi rmed in some reports [ 15 ] . Conversely, in agreement with the present study, several studies in children have failed to show association between vitamin D and insulin resistance [ 16 -20 ] . Even in studies in children where correlation between vitamin D and several components of the metabolic syndrome was found, independent relationships between insulin resistance indices and 25(OH)D were not confi rmed [ 21 -23 ] .
Pacifi co et al. [ 23 ] found that after making appropriate adjustments (including BMI) only blood pressure and the metabolic syndrome remained signifi cantly correlated with vitamin D, but not with IR indices (insulin or HOMA). Similarly, Gannagé-Yared et al. [ 22 ] showed that vitamin D was an independent predictor of systolic blood pressure and fasting glucose, but not of insulin or HOMA-IR. It could be speculated that at this early period of life other factors may infl uence vitamin D and insulin resistance. One such factor could be PTH, as vitamin D defi ciency results in hyperparathyroidism [ 24 , 25 ] , through which glucose metabolism may be aff ected. Higher PTH, but not lower vitamin D, was shown to increase the risk of metabolic syndrome in a recent study [ 26 ] . In the present study PTH levels were similar in the 2 groups, implying that the observed diff erence in vitamin D may not be sufficient to aff ect the PTH level. Furthermore, no clear association between PTH level and insulin resistance indices was found. Another explanation is that the levels of vitamin D, although higher in the SGA group, were below the recently proposed insuffi ciency threshold (32 ng/ml), thus lacking a favorable eff ect on the insulin resistance, which could possibly confer a higher 25(OH)D serum level. A Canadian study in children showed that even a high increment in 25(OH)D level (i.e., 10 ng/ml) correlated with only a slight decrease in the fasting blood glucose level and HOMA-IR [ 18 ] . There is also some evidence for a lower threshold by which vitamin D defi ciency confers negative eff ects on insulin sensitivity [ 27 ] . In a previous study in adolescents, this threshold was estimated at 15 ng/ml [ 27 ] , but application of this threshold to the present study generated no diff erences in insulin resistance indices.
Other studies have demonstrated correlation of high 25(OH)D levels with β-cell function rather than insulin resistance [ 28 ] . This was the case in the present study in SGA group where the higher, positively correlated with 25(OH)D, HOMA-β % imply increased β-cell function. The higher HOMA-β % may attenuate the risk for impaired glucose tolerance posed by the higher HOMA-IR in this group, as the risk of the 2 parameters is regarded as additive [ 29 ] . The higher vitamin D levels in SGA children are diffi cult to interpret, but they could be related to diff erences in adipose tissue between the 2 groups. Although the groups were matched for BMI, waist circumference was about 0. may arise from alterations in adipose tissue due to in utero growth restriction. It has been demonstrated that SGA children have a diminished capacity to store fat subcutaneously (the metabolic equivalent of a partial lipodystrophy) [ 30 ] , thus the SGA children in this study may have had a limited overall storage capacity for vitamin D, with the result that higher circulating vitamin D levels were measured. This hypothesis, however, is diffi cult to prove, as fat partitioning and tissue vitamin D were not studied in the present study. Catch-up growth occurs in over 90 % of SGA children. This was the case for the SGA study children, who were all within the normal range of development at prepuberty, and around the mean, despite their severe growth restriction at birth. The increased insulin resistance indices may therefore be related with both their low birth-weight and subsequent accelerated growth [ 7 , 8 ] .
Obese children were excluded from the present study to avoid the well documented eff ect of adiposity on both 25(OH)D level and insulin resistance status, thus the results of the present study are limited in nonobese SGA children who had experienced catch-up growth.
Other limitations of this study are the small sample size and the use of surrogates of glucose homeostasis, although they correlate well with standard methods [ 10 , 31 ] . The small number of included children could lead to sample bias limiting the possibilities of fi nding other associations beyond those already indentifi ed. Moreover possible selection bias could not be excluded since the fi nal number of included SGA children was considerably smaller than the original target population. The duration of sunshine exposure was based on parental recall, so slight diff erences in time spent outdoors could confound the estimations of vitamin D status. The diff erences in 25(OH)D levels were too large, however, to be attributed to slight deviations in sun-exposure time between the 2 groups belonging to the same cohort and living in the same geographical area (latitude 39 ° N). Finally, as the study was observational, the alterations found in the parameters measured may be physiologically unrelated or due to other unrecognized factors. To the best of authors' knowledge, this is the fi rst study to examine 25(OH)D in a special population with severe in utero growth restriction and a tendency to become insulin resistant early in life. Nonobese SGA born children had higher serum 25(OH)D levels, which were correlated with insulin secretion, but not with insulin resistance indices. Low birth weight appears to be a factor that is correlated independently with both 25(OH)D levels and insulin resistance in this group of children.
